Nina M. van Sorge
Nina M. van Sorge
Amsterdam UMC, location Amsterdam Medical Center
Adresse e-mail validée de amsterdamumc.nl
Titre
Citée par
Citée par
Année
FcγR polymorphisms: implications for function, disease susceptibility and immunotherapy
NM Van Sorge, WL Van Der Pol, JGJ Van de Winkel
Tissue antigens 61 (3), 189-202, 2003
3972003
Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to β-lactam antibiotics
S Dahesh, ME Hensler, NM Van Sorge, RE Gertz, S Schrag, V Nizet, ...
Antimicrobial agents and chemotherapy 52 (8), 2915-2918, 2008
1712008
The group B streptococcal serine-rich repeat 1 glycoprotein mediates penetration of the blood-brain barrier
NM van Sorge, D Quach, MA Gurney, PM Sullam, V Nizet, KS Doran
The Journal of infectious diseases 199 (10), 1479-1487, 2009
1132009
Bacterial glycobiology: rhamnose-containing cell wall polysaccharides in Gram-positive bacteria
MY Mistou, IC Sutcliffe, NM van Sorge
FEMS microbiology reviews 40 (4), 464-479, 2016
1002016
Serine-rich repeat proteins and pili promote Streptococcus agalactiae colonization of the vaginal tract
TR Sheen, A Jimenez, NY Wang, A Banerjee, NM van Sorge, KS Doran
Journal of bacteriology 193 (24), 6834-6842, 2011
922011
Anthrax toxins cooperatively inhibit endocytic recycling by the Rab11/Sec15 exocyst
A Guichard, SM McGillivray, B Cruz-Moreno, NM van Sorge, V Nizet, ...
Nature 467 (7317), 854-858, 2010
892010
Methicillin-resistant Staphylococcus aureus bacterial nitric-oxide synthase affects antibiotic sensitivity and skin abscess development
NM Van Sorge, FC Beasley, I Gusarov, DJ Gonzalez, ...
Journal of Biological Chemistry 288 (9), 6417-6426, 2013
882013
Defense at the border: the blood–brain barrier versus bacterial foreigners
NM Van Sorge, KS Doran
Future microbiology 7 (3), 383-394, 2012
882012
Effective Phagocytosis and Killing of Candida albicans via Targeting FcγRI (CD64) or FcαRI (CD89) on Neutrophils
AB van Spriel, IE van den Herik-Oudijk, NM van Sorge, HA Vilé, ...
The Journal of infectious diseases 179 (3), 661-669, 1999
871999
N‐glycosylated proteins and distinct lipooligosaccharide glycoforms of Campylobacter jejuni target the human C‐type lectin receptor MGL
NM Van Sorge, NMC Bleumink, SJ Van Vliet, E Saeland, WL Van Der Pol, ...
Cellular microbiology 11 (12), 1768-1781, 2009
842009
The classical lancefield antigen of group a Streptococcus is a virulence determinant with implications for vaccine design
NM Van Sorge, JN Cole, K Kuipers, A Henningham, RK Aziz, ...
Cell host & microbe 15 (6), 729-740, 2014
802014
The CiaR response regulator in group B Streptococcus promotes intracellular survival and resistance to innate immune defenses
D Quach, NM Van Sorge, SA Kristian, JD Bryan, DW Shelver, KS Doran
Journal of bacteriology 191 (7), 2023-2032, 2009
802009
Bacterial induction of Snail1 contributes to blood-brain barrier disruption
BJ Kim, BM Hancock, A Bermudez, N Del Cid, E Reyes, NM van Sorge, ...
The Journal of clinical investigation 125 (6), 2473-2483, 2015
772015
Cholera toxin disrupts barrier function by inhibiting exocyst-mediated trafficking of host proteins to intestinal cell junctions
A Guichard, B Cruz-Moreno, B Aguilar, NM van Sorge, J Kuang, ...
Cell host & microbe 14 (3), 294-305, 2013
752013
Activation of brain endothelium by pneumococcal neuraminidase NanA promotes bacterial internalization
A Banerjee, NM Van Sorge, TR Sheen, S Uchiyama, TJ Mitchell, ...
Cellular microbiology 12 (11), 1576-1588, 2010
742010
Severity of Guillain–Barré syndrome is associated with Fcγ Receptor III polymorphisms
NM van Sorge, WL van der Pol, MD Jansen, KPW Geleijns, S Kalmijn, ...
Journal of neuroimmunology 162 (1-2), 157-164, 2005
602005
Anthrax toxins inhibit neutrophil signaling pathways in brain endothelium and contribute to the pathogenesis of meningitis
NM van Sorge, CM Ebrahimi, SM McGillivray, D Quach, M Sabet, ...
PloS one 3 (8), e2964, 2008
582008
A Staphylococcus aureus TIR domain protein virulence factor blocks TLR2-mediated NF-κB signaling
F Askarian, NM Van Sorge, M Sangvik, FC Beasley, JR Henriksen, ...
Journal of innate immunity 6 (4), 485-498, 2014
562014
Bacterial phenotype variants in group B streptococcal toxic shock syndrome
P Sendi, L Johansson, S Dahesh, NM Van Sorge, J Darenberg, ...
Emerging infectious diseases 15 (2), 223, 2009
542009
IVIg inhibits classical pathway activity and anti-GM1 IgM-mediated complement deposition in MMN
S Piepers, MD Jansen, EA Cats, NM van Sorge, LH van den Berg, ...
Journal of neuroimmunology 229 (1-2), 256-262, 2010
482010
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20